Home Biosimilar Antibodies Apoptosis PD-1/PD-L1 Sintilimab (anti-PD-1) For research use only.
Not for use in humans.

Sintilimab (anti-PD-1)

Synonyms: IBI 308

Sintilimab (anti-PD-1, IBI 308) is a fully human IgG4 monoclonal antibody that binds to PD-1 on the surface of T-cells, blocks the PD-1/PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells.

Sintilimab (anti-PD-1)

Click to purchase the isotype control of Sintilimab (anti-PD-1)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 5.81 mg/ml Endotoxin Level: <1 EU/mg
99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Sintilimab (anti-PD-1, IBI 308) is a fully human IgG4 monoclonal antibody that binds to PD-1 on the surface of T-cells, blocks the PD-1/PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells.

Product Details

CAS No. 2072873-06-2
Isotype Human IgG4, κ
Source CHO cells
Sterility 0.2 μM filtered
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Sintilimab (anti-PD-1) | Sintilimab (anti-PD-1) supplier | purchase Sintilimab (anti-PD-1) | Sintilimab (anti-PD-1) cost | Sintilimab (anti-PD-1) manufacturer | order Sintilimab (anti-PD-1) | Sintilimab (anti-PD-1) distributor